Wall Street analysts think Facebook's cryptocurrency payments project will give the company a big boost.Marketsread more
Facebook's reported move into cryptocurrency could amount to the biggest catalyst for digital assets in their decade-long history, some crypto investors say.Bitcoinread more
The Fed is expected to cut rates multiple times, but the reason behind those cuts could have vastly different implications for the market.Marketsread more
"This is going to be the biggest thing that's happened to Facebook in years," says CNBC's Jim Cramer. "It will be vital."Investingread more
A recent Fed survey showed that workers' confidence for finding a new job after losing their current position was at 61.5% in May.Economyread more
These are the stocks posting the largest moves midday.Market Insiderread more
The red-hot market for new public companies in 2019 like Beyond Meat and Chewy could spell bad news for the stock market, Bernstein says.Marketsread more
The "captive carry flight test" evaluates the mock weapon during flight and is the Air Force's latest step in the budding hypersonic arms race between China and Russia.Politicsread more
It's about time to write off high-growth tech stocks, Goldman warns, saying software carries the highest multiples since the tech bubble.Marketsread more
Profits for major U.S. tobacco companies could be cut in half if the FDA adopts a "maximum nicotine" rule within the next 15 years, according to analysts at Morgan Stanley.Tobaccoread more
Former Egyptian president Mohamed Mursi has died in court, state television reported on Monday.World Politicsread more
U.S. stocks were slammed on Thursday, with high-flying technology and biotech shares leading the declines that had the Nasdaq Composite posting its worst session in more than two years.
"The market is coming to its senses in some of the high-flying tech names; it looked like there were some pretty hefty amounts being paid for the prospect of eventual earnings. Any of us in the market more than 15 years feels the hot breath on the backs of our necks when we see such high prices being paid for tech stocks," said Jerry Webman, chief economist at Oppenheimer Funds.
"One of the interesting ironies is when you see a shift towards stocks with pretty low prices and away from momentum that tends to happen when the underlying economy is still growing," Webman added.
The Nasdaq Composite declined as much as 141 points, and ended down 129.79 points, or 3.1 percent, at 4,054.11, its hardest hit since November of 2011.
Momentum stocks including Tesla Motors, Facebook, Google, Priceline Group and Amazon.com declined, along with biotechnology companies, with Pacific Biosciences of California, Zogenix and ChemoCentryx among those hit.
"Clearly investors are nervous about high-flying momentum stocks. There is a rethink on whether better earnings and economic data will support a resumption of the momentum that was driving biotechnology and higher-flying technology stocks earlier in the year," said Kate Warne, investment strategist at Edward Jones.
"We're back to a valuation focus; investors are gravitating towards something tangible, like earnings and revenue," said Jack Ablin, chief investment officer at BMO Private Bank.
"We're entering earnings season and they are not going to have much to show. Investors want to see earnings and cash flow," said Ablin of new technology and biotech firms that have seen their shares run-up on bets for future performance.
EBay fell after reaching an accord with activist investor Carl Icahn to halt his proxy battle by saying it would appoint, at Icahn's urging, an independent director to its board. Family Dollar Stores slid after saying it would cut jobs and close hundreds of stores as the discount retailer struggles to reverse declining sales.
Rite Aid gained after the drugstore chain projected full-year revenue that beat expectations; Bed Bath & Beyond declined after forecasting quarterly profit beneath estimates. Shares of Ally Financial fell as the former financing arm of General Motors made its market debut.
The declined 39.10 points, or 2.1 percent, to 1,833.08, with health care and technology pacing losses that extended to all 10 of its major industry sectors.
The CBOE Volatility Index, a gauge of investor uncertainty, jumped 15 percent to 15.89.
For every stock rising, roughly four declined on the New York Stock Exchange, where 802 million shares traded. Composite volume cleared 3.7 billion.
Equities began the day little changed, with upbeat economic data on the U.S. labor market offsetting disappointing export data from China.
The dollar turned lower against the currencies of major U.S. trading partners; the 10-year Treasury yield used in determining mortgage rates and other consumer loans fell 6 basis points to 2.634 percent.
On the New York Mercantile Exchange, gold futures for June delivery gained $14.60, or 1.1 percent, to $1,320.50 an ounce, while crude-oil futures for May delivery fell 20 cents, or 0.2 percent, to $103.40 a barrel.
The Labor Department reported jobless claims dropped to the lowest level in nearly seven years, with initial claims for state unemployment benefits dropping 32,000 to 300,000 last week, below expectations and the lowest since May 2007.
A separate report had import prices rising 0.6 percent last month after an unrevised 0.9 percent in February.
On Wednesday, stocks rallied after minutes from the Federal Reserve's last session overrode worries about the timing of future interest rate hikes by the central bank.
—By CNBC's Kate Gibson
Coming Up This Week:
Earnings: JP Morgan Chase, Wells Fargo, Fastenal
8:30 a.m.: PPI
9:55 a.m.: Consumer sentiment
More From CNBC.com: